- Preview Available
- Scholarly Journal
First-in-Human Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Rapidly Developed SARS-CoV-2 Therapeutic Antibody, AOD01, in Healthy Adults
Infectious Diseases and Therapy; Philadelphia Vol. 11, Iss. 5, (Oct 2022): 1999-2015.
DOI:10.1007/s40121-022-00681-1
This is a limited preview of the full PDF
Try and log in through your library or institution to see if they have access.